Published in Mol Med on July 24, 2013
Global profiling of co- and post-translationally N-myristoylated proteomes in human cells. Nat Commun (2014) 1.19
Intracellular Delivery of Proteins with Cell-Penetrating Peptides for Therapeutic Uses in Human Disease. Int J Mol Sci (2016) 0.81
Cell-permeable protein therapy for complex I dysfunction. J Bioenerg Biomembr (2014) 0.77
Breaking in and busting out: cell-penetrating peptides and the endosomal escape problem. Biomol Concepts (2017) 0.75
NDUFAF4 variants are associated with Leigh syndrome and cause a specific mitochondrial complex I assembly defect. Eur J Hum Genet (2017) 0.75
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet (2003) 53.59
In vivo protein transduction: delivery of a biologically active protein into the mouse. Science (1999) 10.70
Cellular uptake of the tat protein from human immunodeficiency virus. Cell (1988) 10.19
Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell (1988) 5.26
Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem (2000) 4.02
High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency. Nat Genet (2010) 3.31
Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat Genet (2010) 2.81
Monogenic mitochondrial disorders. N Engl J Med (2012) 2.30
Enzyme replacement for lysosomal diseases. Annu Rev Med (2006) 2.26
Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I. Cell Metab (2010) 2.21
A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy. J Clin Invest (2005) 2.21
Mitochondrial disorders: prevalence, myths and advances. J Inherit Metab Dis (2004) 1.89
NDUFA4 is a subunit of complex IV of the mammalian electron transport chain. Cell Metab (2012) 1.82
Analysis of the assembly profiles for mitochondrial- and nuclear-DNA-encoded subunits into complex I. Mol Cell Biol (2007) 1.82
Mitochondrial dysfunction in Parkinson's disease. Biochim Biophys Acta (2009) 1.77
Assembly factors of human mitochondrial complex I and their defects in disease. IUBMB Life (2010) 1.30
Convergence of amyloid-beta and tau pathologies on mitochondria in vivo. Mol Neurobiol (2010) 1.16
Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene. Brain (2010) 1.11
CIA30 complex I assembly factor: a candidate for human complex I deficiency? Hum Genet (2002) 1.11
FOXRED1, encoding an FAD-dependent oxidoreductase complex-I-specific molecular chaperone, is mutated in infantile-onset mitochondrial encephalopathy. Hum Mol Genet (2010) 1.08
Biological applications of protein transduction technology. Trends Biotechnol (2003) 1.07
TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice. J Clin Invest (2006) 1.03
Early complex I assembly defects result in rapid turnover of the ND1 subunit. Hum Mol Genet (2012) 1.02
Enzyme-replacement therapy for metabolic storage disorders. Lancet Neurol (2004) 1.02
Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity. Gene Ther (2002) 1.01
TAT-mediated protein transduction and targeted delivery of fusion proteins into mitochondria of breast cancer cells. DNA Repair (Amst) (2005) 0.99
Combined OXPHOS complex I and IV defect, due to mutated complex I assembly factor C20ORF7. J Inherit Metab Dis (2011) 0.98
Targeting proteins to mitochondria using TAT. Mol Genet Metab (2003) 0.96
A TAT-frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich's ataxia mouse model. Hum Mol Genet (2011) 0.94
Screening for active small molecules in mitochondrial complex I deficient patient's fibroblasts, reveals AICAR as the most beneficial compound. PLoS One (2011) 0.92
Successful TAT-mediated enzyme replacement therapy in a mouse model of mitochondrial E3 deficiency. J Mol Med (Berl) (2010) 0.89
TAT-mediated delivery of LAD restores pyruvate dehydrogenase complex activity in the mitochondria of patients with LAD deficiency. Mol Ther (2008) 0.86
HRPAP20: a novel calmodulin-binding protein that increases breast cancer cell invasion. Oncogene (2006) 0.86
TAT fusion protein transduction into isolated mitochondria is accelerated by sodium channel inhibitors. Biochemistry (2010) 0.84
Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo. Bioconjug Chem (2011) 0.84
Intracellular delivery of full length recombinant human mitochondrial L-Sco2 protein into the mitochondria of permanent cell lines and SCO2 deficient patient's primary cells. Biochim Biophys Acta (2010) 0.82
TAT opens the door. Mol Ther (2008) 0.82
Transduction of functionally active TAT fusion proteins into cornea. Exp Eye Res (2004) 0.79
Transducing proteins to manipulate intracellular targets. J Mol Med (Berl) (2003) 0.78
Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet (2007) 3.55
Control of pancreatic β cell regeneration by glucose metabolism. Cell Metab (2011) 3.35
Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann Neurol (2004) 2.09
Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet (2005) 2.06
Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am J Hum Genet (2006) 1.97
Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. Am J Hum Genet (2008) 1.71
Acute infantile liver failure due to mutations in the TRMU gene. Am J Hum Genet (2009) 1.61
Mechanism of action of interleukin-2 (IL-2)-Bax, an apoptosis-inducing chimaeric protein targeted against cells expressing the IL-2 receptor. Biochem J (2003) 1.59
C6ORF66 is an assembly factor of mitochondrial complex I. Am J Hum Genet (2008) 1.56
The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy. Blood (2013) 1.55
Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood. Am J Hum Genet (2008) 1.48
Mice deficient in ribosomal protein S6 phosphorylation suffer from muscle weakness that reflects a growth defect and energy deficit. PLoS One (2009) 1.24
Early prenatal ventriculomegaly due to an AIFM1 mutation identified by linkage analysis and whole exome sequencing. Mol Genet Metab (2011) 1.20
FASTKD2 nonsense mutation in an infantile mitochondrial encephalomyopathy associated with cytochrome c oxidase deficiency. Am J Hum Genet (2008) 1.13
Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain. J Biol Chem (2013) 1.11
Mutation in mitochondrial ribosomal protein MRPS22 leads to Cornelia de Lange-like phenotype, brain abnormalities and hypertrophic cardiomyopathy. Eur J Hum Genet (2010) 1.07
The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition. J Biol Chem (2010) 1.05
The interplay between SUCLA2, SUCLG2, and mitochondrial DNA depletion. Biochim Biophys Acta (2011) 1.05
Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene. Am J Hum Genet (2009) 1.05
Infantile mitochondrial hepatopathy is a cardinal feature of MEGDEL syndrome (3-methylglutaconic aciduria type IV with sensorineural deafness, encephalopathy and Leigh-like syndrome) caused by novel mutations in SERAC1. Am J Med Genet A (2013) 1.04
Familial neonatal isolated cardiomyopathy caused by a mutation in the flavoprotein subunit of succinate dehydrogenase. Eur J Hum Genet (2010) 1.04
Kinetic properties of mutant human thymidine kinase 2 suggest a mechanism for mitochondrial DNA depletion myopathy. J Biol Chem (2002) 1.04
Targeted cancer therapy with gonadotropin-releasing hormone chimeric proteins. Expert Rev Anticancer Ther (2004) 1.03
Mitochondrial complex I deficiency caused by a deleterious NDUFA11 mutation. Ann Neurol (2008) 1.02
TAT-based drug delivery system--new directions in protein delivery for new hopes? Expert Opin Drug Deliv (2009) 1.01
The effect of mutated mitochondrial ribosomal proteins S16 and S22 on the assembly of the small and large ribosomal subunits in human mitochondria. Mitochondrion (2008) 1.00
Mitochondrial complex III deficiency associated with a homozygous mutation in UQCRQ. Am J Hum Genet (2008) 0.99
Agenesis of corpus callosum and optic nerve hypoplasia due to mutations in SLC25A1 encoding the mitochondrial citrate transporter. J Med Genet (2013) 0.98
Antibiotic effects on mitochondrial translation and in patients with mitochondrial translational defects. Mitochondrion (2009) 0.97
Leukoencephalopathy with accumulated succinate is indicative of SDHAF1 related complex II deficiency. Orphanet J Rare Dis (2012) 0.96
Apoptosis-like death, an extreme SOS response in Escherichia coli. MBio (2014) 0.95
l-arginine:glycine amidinotransferase (AGAT) deficiency: clinical presentation and response to treatment in two patients with a novel mutation. Mol Genet Metab (2010) 0.95
Diagnostic serum glycosylation profile in patients with intellectual disability as a result of MAN1B1 deficiency. Brain (2014) 0.95
NDUFS4 mutations cause Leigh syndrome with predominant brainstem involvement. Mol Genet Metab (2009) 0.94
Cardiac-targeted transgenic mutant mitochondrial enzymes: mtDNA defects, antiretroviral toxicity and cardiomyopathy. Cardiovasc Toxicol (2008) 0.93
Screening for active small molecules in mitochondrial complex I deficient patient's fibroblasts, reveals AICAR as the most beneficial compound. PLoS One (2011) 0.92
Infantile cerebellar-retinal degeneration associated with a mutation in mitochondrial aconitase, ACO2. Am J Hum Genet (2012) 0.92
Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-alpha, IL-6 and IL-1 beta: possible relevance to multiple sclerosis. J Neuroimmunol (2003) 0.91
Depletion of the other genome-mitochondrial DNA depletion syndromes in humans. J Mol Med (Berl) (2002) 0.89
Successful TAT-mediated enzyme replacement therapy in a mouse model of mitochondrial E3 deficiency. J Mol Med (Berl) (2010) 0.89
A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease. Eur J Neurosci (2005) 0.89
Toward genotype phenotype correlations in GFM1 mutations. Mitochondrion (2011) 0.87
TAT-mediated delivery of LAD restores pyruvate dehydrogenase complex activity in the mitochondria of patients with LAD deficiency. Mol Ther (2008) 0.86
The unique neuroradiology of complex I deficiency due to NDUFA12L defect. Mol Genet Metab (2008) 0.85
TMEM70 mutations are a common cause of nuclear encoded ATP synthase assembly defect: further delineation of a new syndrome. J Med Genet (2010) 0.85
α-Synuclein expression selectively affects tumorigenesis in mice modeling Parkinson's disease. PLoS One (2011) 0.84
Protection of a ceramide synthase 2 null mouse from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalization. J Biol Chem (2013) 0.84
Rat cardiac mitochondrial sub-populations show distinct features of oxidative phosphorylation during ischemia, reperfusion and ischemic preconditioning. Cell Physiol Biochem (2012) 0.84
2-Hydroxylated sphingomyelin profiles in cells from patients with mutated fatty acid 2-hydroxylase. Lipids Health Dis (2011) 0.82
Mutated NDUFS6 is the cause of fatal neonatal lactic acidemia in Caucasus Jews. Eur J Hum Genet (2009) 0.82
Leigh disease presenting in utero due to a novel missense mutation in the mitochondrial DNA-ND3. Mol Genet Metab (2010) 0.81
A novel approach for enzyme replacement therapy. The use of phenylalanine hydroxylase-based fusion proteins for the treatment of phenylketonuria. J Biol Chem (2007) 0.81
Nonylphenol ethoxylate plastic additives inhibit mitochondrial respiratory chain complex I. Clin Chem (2009) 0.81
The effect of antiepileptic drugs on mitochondrial activity: a pilot study. J Child Neurol (2010) 0.80
Mitochondrial performance in heat acclimation--a lesson from ischemia/reperfusion and calcium overload insults in the heart. Am J Physiol Regul Integr Comp Physiol (2012) 0.80
IL2-caspase3 chimeric protein controls lymphocyte reactivity by targeted apoptosis, leading to amelioration of experimental autoimmune encephalomyelitis. Int Immunopharmacol (2009) 0.80
alpha-Synuclein abnormalities in mouse models of peroxisome biogenesis disorders. J Neurosci Res (2010) 0.79
Using apoptosis for targeted cancer therapy by a new gonadotropin releasing hormone-DNA fragmentation factor 40 chimeric protein. Clin Cancer Res (2003) 0.79
Utilizing Fcepsilon-Bak chimeric protein for studying IgE-FcepsilonRI interactions. Clin Immunol (2004) 0.79
Elevated plasma citrulline: look for dihydrolipoamide dehydrogenase deficiency. Eur J Pediatr (2013) 0.79
Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury. Int J Exp Pathol (2005) 0.79
Dietary copper supplementation restores β-cell function of Cohen diabetic rats: a link between mitochondrial function and glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab (2013) 0.78
IL-1β hampers glucose-stimulated insulin secretion in Cohen diabetic rat islets through mitochondrial cytochrome c oxidase inhibition by nitric oxide. Am J Physiol Endocrinol Metab (2014) 0.78
Mitochondrial OXPHOS function is unaffected by chronic azithromycin treatment. J Cyst Fibros (2013) 0.77
Utilizing chimeric proteins for exploring the cellular fate of endogenous proteins. Biochem Biophys Res Commun (2002) 0.77
Human granulosa luteal cell oxidative phosphorylation function is not affected by age or ovarian response. Fertil Steril (2012) 0.77
IL-2-granzyme A chimeric protein overcomes multidrug resistance (MDR) through a caspase 3-independent apoptotic pathway. Int J Cancer (2011) 0.76
Utilizing a GnRH-based chimeric protein for the detection of adenocarcinoma. Int J Oncol (2005) 0.75
Eliminating the six N-terminal amino acids of the caspase 3 large subunit improved production of a biologically active IL2-Caspase3 chimeric protein. Biotechnol Prog (2012) 0.75
Novel selective human mitochondrial kinase inhibitors: design, synthesis and enzymatic activity. Bioorg Med Chem (2007) 0.75
Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment: sCD40L-caspase 3 chimeric protein for treating B-cell malignancies. Cancer (2012) 0.75
Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number. Am J Hum Genet (2016) 0.75
A fusion protein composed of IL-2 and caspase-3 ameliorates the outcome of experimental inflammatory colitis. Ann N Y Acad Sci (2009) 0.75